Drugs / Bifendatatum
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT01483248 Comparator | Oct 2010 → Oct 2013 | cirrhosis of liver | S-Evans Biosciences Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifendatatum | “Bifendatatum” NCT01483248 ↗ |